Sample
Human plasma, serum, milk, urine, saliva, CSF, cell culture, and cell lysate samples.
Intended Use
Human Lactoferrin ELISA (Enzyme-Linked Immunosorbent Assay) Kit is designed for detection of lactoferrin in human plasma, serum, milk, urine, saliva, CSF, cell culture, and cell lysate samples.
Contents of Kit
1.Human Lactoferrin Microplate: A 96-well polystyrene microplate (12 strips of 8 wells) coated with a polyclonal antibody against human lactoferrin.
2.Sealing Tapes: Each kit contains 3 precut, pressure sensitive sealing tapes that can be cut to fit the format of the individual assay.
3.Human Lactoferrin Standard: Human lactoferrin in a buffered protein base (42 ng, lyophilized).
4.Biotinylated Human Lactoferrin Antibody (50x): A 50-fold concentrated biotinylated polyclonal antibody against human lactoferrin (120 μl).
5.MIX Diluent Concentrate (10x): A 10-fold concentrated buffered protein base (30 ml).
6.Wash Buffer Concentrate (20x): A 20-fold concentrated buffered surfactant (30 ml, 2 bottles).
7.SP Conjugate (100x): A 100-fold concentrate (80 μl).
8.Chromogen Substrate (1x): A stabilized peroxidase chromogen substrate tetramethylbenzidine (7 ml).
9.Stop Solution (1x): A 0.5 N hydrochloric acid solution to stop the chromogen substrate reaction (11 ml).
Storage
1.Upon arrival, immediately store components of the kit at recommended temperatures up to the expiration date.
2.Store SP Conjugate and Biotinylated Antibody at -20°C.
3.Store Microplate, Diluent Concentrate (10x), Wash Buffer, Stop Solution, and Chromogen Substrate at 2-8°C.
4.Unused microplate wells may be returned to the foil pouch with the desiccant packs and resealed. May be stored for up to 30 days in a vacuum desiccator.
5.Store Standard at 2-8°C before reconstituting with Diluent and at -20°C after reconstituting with Diluent.
Precision
The minimum detectable dose of human lactoferrin as calculated by 2SD from the mean of a zero standard was established to be 0.13 ng/ml.
• Intra-assay precision was determined by testing three plasma samples twenty times in one assay.
• Inter-assay precision was determined by testing three plasma samples in twenty assays.

General Description
Lactoferrin (lactotransferrin, growth-inhibiting protein 12, LTF) is an 80 kDa iron-binding glycoprotein produced by many exocrine glands with a major constituent in the secondary granules of neutrophilic leukocytes. It is found mainly in the oral cavity where it can come into direct contact with pathogens, such as viruses, bacteria, etc. Lactoferrin is present in maternal milk, saliva, tears, vaginal secretions, semen, bronchoalveolar lavage fluid, and specific granules of polymorphonuclear leukocytes [PMNs] (1). Serum lactoferrin concentration is much higher during inflammation (2). Lactoferrin is known to be an immune modulator or enhancer due to specific receptors for lactoferrin that are found on many key immune cells, such as lymphocytes, monocytes, and macrophages. It is also considered an antioxidant that scavenges free iron, helping to prevent uncontrolled iron-based free radical reactions, thus protecting certain cells from peroxidation. Lactoferrin is known to be directly involved in the up-regulation of natural killer (NK) cell activity (3). It directly inhibits viruses by binding to viral receptor sites, thus preventing the virus from infecting healthy cells. Lactoferrin has a direct bactericidal function to certain bacteria, such as Streptococcus mutans, Vibrio cholerae, Escherichia coli, Actinobacillus actinomycetemcomitans, and Legionella pneumophila; it also has a bacteriostatic effect that deprives iron-requiring bacteria of this essential growth nutrient (1, 3-4).
Standard Curve
The typical data is provided for reference only. Individual laboratory means may vary from the values listed. Variations between laboratories may be caused by technique differences.

The curve is provided for illustration only. A standard curve should be generated each time the assay is performed.

Citations
Publication ()
Have you cited DEIA1556 in a publication?
Let us know and earn a reward for your research.
Effect of pasteurisation and high-pressure processing on selected bioactive components in human milk – An experimental study
Miroslava Jandová, Michaela Fišerová, Pavla Paterová, Pavel Měřička, Jan Malý, Marian Kacerovský, Eliška Kovaříková, Jan Strohalm, Kateřina Demnerová, Jana Kadavá, Hana Sýkorová, Radomír Hyšpler, Alena Tichá, Dana Čížková, Milan Houška, Aleš Bezrouk
Applications: ELISA
Reactive species: Human
"Abstract: High-pressure processing (HPP) represents a promising alternative to conventional Holder pasteurisation (HoP) used by human milk banks worldwide. The objective of this study was to identify whether the HPP would achieve the same or better retention of the content of selected analytes than the HoP. Samples collected from 15 breast milk donors were processed in four ways: i) no treatment; ii) HoP; iii) HPP in cycles (350 MPa, 4 cycles); iv) continuous HPP (350 MPa, 20 min). The content of secretory immunoglobulin A (sIgA), lactoferrin and lysozyme was determined using commercially available ELISA kits, and the lipase activity was assessed using an A-lipase activity assay kit. Data were compared statistically using paired t-tests. HoP significantly reduced the content of lysozyme and lactoferrin as well as lipase activity (P < 0.001). Cycled HPP significantly decreased lipase activity (P = 0.002), while continuous HPP led to a significant decrease in lysozyme content (P = 0.001) and lipase activity (P = 0.014). Cycled HPP showed high retention of pretreatment levels of lysozyme – median 99 (88; 99%), lactoferrin – 84 (66; 105%), and sIgA content – 83 (28; 117%). Among the studied treatment regimens, the best preservation of initial levels of bioactive components was achieved using HPP at 350 MPa in cycles."
Article snippet: Lactoferrin content was determined using a human lactoferrin ELISA kit (CD Creative Diagnostics, USA) designed for the detection of lactoferrin in human milk; our procedure followed the manufacturer's instructions. The lower limit of test sensitivity was 0.13 ng·mL –1.
Figure 1. Residual lactoferrin levels (%) after Holder pasteurisation, high-pressure processing (HPP) in cycles, and continuous HPP.